Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1259890.RAoiZ1uuR6TwPysA0Pz7HgZa12KanAALjtVGXJGKgJbWo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1259890.RAoiZ1uuR6TwPysA0Pz7HgZa12KanAALjtVGXJGKgJbWo130_assertion type Assertion NP1259890.RAoiZ1uuR6TwPysA0Pz7HgZa12KanAALjtVGXJGKgJbWo130_head.
- NP1259890.RAoiZ1uuR6TwPysA0Pz7HgZa12KanAALjtVGXJGKgJbWo130_assertion description "[We have previously reported that decreased expression of PTEN in lung cancer PC9 cells harboring an EGFR-activating mutation (del E746-A750) results in acquisition of resistance to EGFR-TKIs, gefitinib and erlotinib, accompanied by enhanced phosphorylation of Akt and decreased nuclear translocation of a transcription factor EGR-1 [8].]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1259890.RAoiZ1uuR6TwPysA0Pz7HgZa12KanAALjtVGXJGKgJbWo130_provenance.
- NP1259890.RAoiZ1uuR6TwPysA0Pz7HgZa12KanAALjtVGXJGKgJbWo130_assertion evidence source_evidence_literature NP1259890.RAoiZ1uuR6TwPysA0Pz7HgZa12KanAALjtVGXJGKgJbWo130_provenance.
- NP1259890.RAoiZ1uuR6TwPysA0Pz7HgZa12KanAALjtVGXJGKgJbWo130_assertion SIO_000772 25638724 NP1259890.RAoiZ1uuR6TwPysA0Pz7HgZa12KanAALjtVGXJGKgJbWo130_provenance.
- NP1259890.RAoiZ1uuR6TwPysA0Pz7HgZa12KanAALjtVGXJGKgJbWo130_assertion wasDerivedFrom befree-2016 NP1259890.RAoiZ1uuR6TwPysA0Pz7HgZa12KanAALjtVGXJGKgJbWo130_provenance.
- NP1259890.RAoiZ1uuR6TwPysA0Pz7HgZa12KanAALjtVGXJGKgJbWo130_assertion wasGeneratedBy ECO_0000203 NP1259890.RAoiZ1uuR6TwPysA0Pz7HgZa12KanAALjtVGXJGKgJbWo130_provenance.